Andreia Cristina de Melo
Overview
Explore the profile of Andreia Cristina de Melo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arenhardt M, Giannecchini G, de Andrade D, Gomes L, Dos Santos M, da Silva J, et al.
Crit Rev Oncol Hematol
. 2025 Mar;
210:104695.
PMID: 40068805
Introduction: Vulvar squamous cell carcinoma (VSCC) is a rare gynecological tumor with limited treatment options for advanced stages. Current chemotherapy, adapted from cervical cancer protocols, often results in poor outcomes....
2.
Nogueira Rodrigues A, Souto A, de Andrade D, Gomes L, Koide S, E Silva R, et al.
Front Mol Biosci
. 2025 Feb;
12:1524594.
PMID: 40007558
Background: Along with mutation status, homologous recombination deficiency (HRD) testing is a prognostic and predictive biomarker for poly-ADP-ribose polymerase (PARP) inhibitor therapy indication in high-grade epithelial ovarian, fallopian tube, or...
3.
Oza A, Lisyanskaya A, Fedenko A, de Melo A, Shparyk Y, Rakhmatullina I, et al.
Lancet Oncol
. 2025 Feb;
26(2):249-264.
PMID: 39914419
Background: In the ARIEL4 trial of rucaparib versus standard-of-care chemotherapy in patients with relapsed BRCA-mutated ovarian carcinoma, the primary endpoint was met, showing improved investigator-assessed progression-free survival with rucaparib. Here,...
4.
Lobo M, Duprat Neto J, Silva M, Munhoz R, de Melo A, Pinheiro R, et al.
J Surg Oncol
. 2025 Jan;
PMID: 39865497
No abstract available.
5.
da Silva J, De Oliveira L, Albuquerque L, Thuler L, de Melo A
Lancet Reg Health Am
. 2025 Jan;
39():100900.
PMID: 39839681
No abstract available.
6.
Oaknin A, Monk B, de Melo A, Kim H, Kim Y, Lisyanskaya A, et al.
Eur J Cancer
. 2025 Jan;
216:115146.
PMID: 39798514
Aim: Cemiplimab has demonstrated significantly longer survival than physician's choice of chemotherapy in patients with recurrent cervical cancer after first-line platinum-containing chemotherapy. We report the final survival analysis from the...
7.
da Silva J, Thuler L, de Melo A
BMC Cancer
. 2025 Jan;
25(1):18.
PMID: 39762817
Background: Breast cancer (BC) has exhibited varied epidemiological trends based on distinct age categories. This research aimed to explore the incidence and mortality rates of BC within pre-defined age groups...
8.
Epidemiological landscape of tongue cancer in younger patients in a National Cancer Center in Brazil
da Silva Souto A, da Silva B, Heimlich F, Soares O, Dias F, de Lima Araujo L, et al.
Sci Rep
. 2024 Dec;
14(1):30573.
PMID: 39706848
This study investigates the changing epidemiological profile of tongue squamous cell carcinoma (SCC) to young patients, highlighting its rising incidence among non-traditional risk groups. A retrospective descriptive study was conducted,...
9.
Miranda A, da Silva J, de Andrade D, Gomes L, Dos Santos M, Arruda G, et al.
Crit Rev Oncol Hematol
. 2024 Sep;
204:104517.
PMID: 39299408
Purpose: This scoping review aims to evaluate the evidence for stereotactic body radiotherapy (SBRT) boost as a potential alternative for brachytherapy (BCT) in treating cervical cancer. Material And Methods: A...
10.
Parreiras F, Drummond-Lage A, de Souza Brandao M, Silva L, Geo L, Andrade B, et al.
Int J Cancer Med
. 2024 Aug;
7(1):28-34.
PMID: 39193355
Methods: Relative caregiver of melanoma end of life patients were invited to participate in a specific interview answering questions for the purpose of gathering information regarding symptoms and patients' complaints...